Skip to content
value.today

WaferGen Bio-systems, Inc.

🇺🇸 Fremont, California, USABiotechnologyFounded 2005

Formerly La Burbuja Cafe, Inc.

Total raised
$56 M
4 rounds on record
Latest round
$14 M
Aug 2013
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of WaferGen Bio-systems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2013$14 MNo. 4$10 to $50 million

WaferGen Bio-systems, Inc.: Raise no. 4, Aug 2013

Investors in this round

179 investors had bought by the notice of Sep 10, 2013: 179 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$14 M of $15 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,166,850
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Ivan Dean Trifunovich · Executive Officer, Director
  • John Dean Harland · Executive Officer
  • Alnoor Shivji · Director
  • Joel Dean Kanter · Director
  • Joseph Dean Pesce · Director
  • Makoto Dean Kaneshiro · Director
  • R. Dean Hautamaki · Director
  • Robert Coradini · Director
  • Scott Davidson · Director
  • Timothy Dean Triche · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · New York, New YorkSold in AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, LA, MA, MD, MI, MN, MO, MS, ND, NH, NJ, NY, OH, OK, OR, PA, RI, SC, TX, UT, VA, WA, WI, WY

Remarks in the notice

  • On the amounts: “Minimum investment amount may be waived. Total offering amount may be increased by up to $2,250,000 to cover over-allotments, if any.”

Signed by John Harland, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 10, 2013. Read the notice at the SEC.

equity, optionsSEC
May 2011$31 MNo. 3$10 to $50 million

WaferGen Bio-systems, Inc.: Raise no. 3, May 2011

Investors in this round

22 investors had bought by the notice of Jun 1, 2011: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,138,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Alnoor Shivji · Director, Executive Officer
  • Donald Dean Huffman · Executive Officer
  • Mona Dean Chadha · Executive Officer
  • Joel Dean Kanter · Director
  • Makoto Dean Kaneshiro · Director
  • R. Dean Hautamaki · Director
  • Robert Coradini · Director
  • Robert J. Hariri · Director
  • Timothy Dean Triche · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Madison Williams and Company (CRD 149530) · New York, New YorkSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
  • Summer Street Research Partners (CRD 127142) · Boston, MassachusettsSold in AZ, CA, GA, IL, MA, MD, MS, NY, WI
  • Oppenheimer & Co. Inc. (CRD 249) · New York, New YorkSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY

Remarks in the notice

  • On the use of proceeds: “Proceeds used for general working capital.”

Signed by Alnoor Shivji, CEO, President & Chairman of the Board. Source: SEC Form D, newest notice filed Jun 1, 2011. Read the notice at the SEC.

equity, debt, optionsSEC
Nov 2009$5 MNo. 2$2 to $10 million

WaferGen Bio-systems, Inc.: Raise no. 2, Nov 2009

Investors in this round

37 investors had bought by the notice of Feb 24, 2010: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities, other: Units consisting of one share of common stock and one warrant to purchase 25% of one share of common stock.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$381,420
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Alnoor Shivji · Executive Officer, Director
  • Raymond Dean Hautamaki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Newport Coast Securities, Inc. (CRD 16944) · Irvine, CaSold in no state named
  • Spencer Trask Ventures, Inc. (CRD 28373) · New York, NySold in no state named
  • Gilford Securities Incorporated (CRD 8076) · New York, NySold in no state named

Remarks in the notice

  • On fees: “In addition to the dollar amount, sales commissions included warrants to purchase a total of 118,644 shares of stock at an exercise price of $2.50 per whole share.”

Signed by Hector Brush, Principal Financial Officer. Source: SEC Form D, newest notice filed Feb 24, 2010. Read the notice at the SEC.

equity, optionsSEC
May 2009$6 MNo. 1$2 to $10 million

WaferGen Bio-systems, Inc.: Raise no. 1, May 2009

Investors in this round

32 investors had bought by the notice of Sep 15, 2009: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities, other: Units consisting of one share of common stock and one warrant to purchase 30% of one share of common stock.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$309,356
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Alnoor Shivji · Director, Executive Officer · Chief Executive Officer, President and Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Spencer Trask Ventures, Inc. (CRD 28373) · broker-dealer Spencer Trask Ventures, Inc. (CRD 28373) · New York, NySold in no state named

Signed by Alnoor Shivji, Chairman, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 15, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • WaferGen Bio-systems, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2013).

    SEC Form D · Sep 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2013

That is all the official record says: WaferGen Bio-systems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in WaferGen Bio-systems, Inc.
InvestorKindAmountRoundRoleSource
Great Point Partners LLCFund or asset managernot statednot statedHeld Series A-1 preferred stock (Form 3, 2012)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 179 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by WaferGen Bio-systems, Inc.
NameRoleNamed in
Ivan Dean TrifunovichExecutive officerSep 2013
John Dean HarlandExecutive officerSep 2013
Alnoor ShivjiExecutive officerJun 2011
Donald Dean HuffmanExecutive officerJun 2011
Mona Dean ChadhaExecutive officerJun 2011
Alnoor ShivjiDirectorSep 2013
Ivan Dean TrifunovichDirectorSep 2013
Joel Dean KanterDirectorSep 2013
Joseph Dean PesceDirectorSep 2013
Makoto Dean KaneshiroDirectorSep 2013
R. Dean HautamakiDirectorSep 2013
Robert CoradiniDirectorSep 2013
Scott DavidsonDirectorSep 2013
Timothy Dean TricheDirectorSep 2013
Robert J. HaririDirectorJun 2011
Raymond Dean HautamakiDirectorFeb 2010